ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of a Diabetic- and a Kidney-like Environment on Gene and Protein Expression in Cultured EC and SMC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01423279
Recruitment Status : Recruiting
First Posted : August 25, 2011
Last Update Posted : March 29, 2018
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:
This research is NOT part of an interventional trial, however the investigators use umbilical cord after birth for isolating endothelial and smooth muscle cells for academic research.

Condition or disease
Endothelial Dysfunction Disorder of Smooth Muscle

Detailed Description:
Isolation and culturing of endothelial and smooth muscle muscles for academic research

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Other
Time Perspective: Other
Official Title: The Effect of a Diabetic- and a Kidney-like Environment on Gene and Protein Expression in Mono- and Co-cultured Endothelial and Smooth Muscle Cells
Study Start Date : February 2013
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. The effect of a Diabetic- and a Kidney-like environment on gene and protein expression in mono- and co-cultured endothelial and smooth muscle cells [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Women after normal birth
Criteria

Inclusion Criteria:

  • normal pregnancy

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01423279


Locations
Israel
Laboratory of Renal Physiology, Meir Medical Center , Recruiting
Kfar Saba, Israel
Contact: Tali Zitman-Gal, PhD    +972-9-7472401    tali.gal@clalit.org.il   
Principal Investigator: Tali Zitman-Gal, PhD         
Sponsors and Collaborators
Meir Medical Center
Investigators
Study Director: Sydney Benchetrit, MD Nephrology dept. Meir Medical Center, Kfar Saba , Israel